Differences in Patient Access to Newly Approved Antibacterial Drugs in EU/EEA Countries
The introduction of antibiotics in the beginning of the 20th century was one of the most important scientific breakthroughs in history. However, in recent decades, the growing threat of antimicrobial resistance (AMR) has shown the limitations of the current research and development programs for new...
Saved in:
Main Authors: | Anelia Zasheva (Author), Elina Batcheva (Author), Kremena Dimitrova Ivanova (Author), Antoniya Yanakieva (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.
by: Katherine C Sharrock, et al.
Published: (2022) -
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
by: Katherine C. Sharrock, et al.
Published: (2022) -
Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
by: Aya Olivia Nakitanda, et al.
Published: (2020) -
Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
by: Aya Olivia Nakitanda, et al.
Published: (2023) -
Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines
by: Fernando Durães, et al.
Published: (2019)